SCHEMBL113349

SCHEMBL113349

CC1CN(c2ccc(F)cc2-c2cnc(N3CCC([S+](C)[O-])CC3)nc2)CCN1C(=O)Cn1c(=O)[nH]c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 5/20 0.50
KCNH2 Q12809 2/20 0.50
WDR5 P61964 9/20 0.36
TNF P01375 1/20 0.36
CHRM4 P08173 2/20 0.36
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
CDK9 P50750 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113350 0.88 CXCR3 (0.51) CXCR3KCNH2WDR5TNFCHRM4
SCHEMBL167594 0.85 CXCR3 (0.46) CXCR3KCNH2TNFCHRM4GRIN1
SCHEMBL15925539 0.84 CXCR3 (0.44) CXCR3KCNH2CHRM4GRIN1GRIN2B
SCHEMBL164088 0.83 PREP (0.40) CXCR3WDR5TNF
SCHEMBL115409 0.83 CXCR3 (0.57) CXCR3KCNH2CHRM4GRIN1GRIN2B
SCHEMBL165175 0.83 CXCR3 (0.62) CXCR3KCNH2TNFCHRM2CHRM1
SCHEMBL3728323 0.81 CXCR3 (0.48) CXCR3KCNH2GRIN1GRIN2BCHRM2
SCHEMBL169464 0.80 CXCR3 (0.52) CXCR3KCNH2TNFCHRM2CHRM1
SCHEMBL167757 0.80 CXCR3 (0.73) CXCR3KCNH2GRIN1GRIN2B
SCHEMBL163879 0.79 CXCR3 (0.62) CXCR3KCNH2GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP claimed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO claimed
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed